Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of PUR1900 (Inhaled Itraconazole) in Healthy Volunteers and Asthmatics
NCT03479411Phase 1Completed
- Sponsor
- Pulmatrix, Inc.
- Start
- Feb 2018
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of itraconazole in asthma (6 arms), sponsored by Pulmatrix, Inc. Primary endpoint: Number of participants with treatment-related Adverse Events at Day 28. Started Feb 2018; status: completed.
02
Drugs
itraconazole
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03479411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03479411.